Reynolds M. Delgado III, M.D.
NPI 1720024466ActiveIndividual· Internal Medicine, Cardiovascular Disease· Houston, TX
Internal Medicine, Cardiovascular Disease (M.D.) in Houston, Texas, trained at University of Texas Southwestern Medical School at Dallas (class of 1991). Their prescriptions cost Medicare Part D more than their services did: $2,767,817 for 5,479 claims, against $384,296 paid for services in 2024. Boehringer Ingelheim Pharmaceuticals, Inc. was the largest of 20 companies reporting payments in 2025, $44,570 in all, mostly speaking and faculty fees.
Overview
| NPI | 1720024466 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jun 21, 2006 |
| Last updated in NPPES | Oct 20, 2022 |
| Certified by provider | Oct 20, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Cardiovascular Disease Primary | 207RC0000X | J1968 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Cardiovascular Disease (Cardiology) (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 344 |
|---|---|
| Services billed | 6,094 across 54 procedure codes |
| Paid by Medicare | $384,296 |
Part D prescriptions in 2024
| Prescriptions (claims) | 5,479 · 14,054 30-day fills |
|---|---|
| Patients | 407 |
| Total drug cost | $2,767,817 |
| Generic share | 84% of claims |
Education and affiliations
| Medical school | University of Texas Southwestern Medical School at Dallas |
|---|---|
| Graduation year | 1991 |
| Medicare specialty | Cardiovascular Disease (Cardiology) |
| Telehealth | Offers telehealth |
Medical group
- St. Luke's Diagnostic Cath Lab, LLPHouston, TX · 15 clinicians
Hospital affiliation
- Baylor St Lukes Medical CenterHouston, TX
Industry payments (Open Payments)
- 2025$44,570 · 119 payments from 20 companies
- 2024$59,604 · 170 payments from 27 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20,726 | 13 |
| Lilly USA, LLC | $7,650 | 6 |
| Alnylam Pharmaceuticals Inc. | $7,002 | 11 |
| Bridgebio Pharma, Inc. | $3,249 | 10 |
| Astrazeneca Pharmaceuticals LP | $2,367 | 12 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$35,975 · 17 payments
- Consulting Fee$4,715 · 3 payments
- Food and Beverage$2,765 · 95 payments
- Travel and Lodging$1,098 · 3 payments
- Entertainment$17.29 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Cardiovascular Disease providers in Houston
- 1104014315
- 1518929256
- 1548301252
- 1619113073
- 1124219225
- 1871868497
- 1245410018
- 1023842515
- 1356865737
- 1366611485
- 1508930181
- 1780977132
All Internal Medicine, Cardiovascular Disease providers in Texas →